Trademark Overview
On Thursday, March 3, 2005, a trademark application was filed for XENPACE with the United States Patent and Trademark Office. The USPTO has given the XENPACE trademark a serial number of 78579322. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, November 22, 2005. This trademark is owned by Pfizer Inc.. The XENPACE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations